Clinical application progress of granulocyte transfusion
10.13303/j.cjbt.issn.1004-549x.2022.11.023
- VernacularTitle:粒细胞输注的临床应用进展
- Author:
Jianjun WU
1
;
Xin CUI
2
;
Shuming ZHAO
1
Author Information
1. Guiqian International General Hospital
2. Guizhou Blood Center
- Publication Type:Journal Article
- Keywords:
granulocytes;
transfusion;
cancer-killing activity;
anti-infection treatment;
anti-tumor treatment
- From:
Chinese Journal of Blood Transfusion
2022;35(11):1180-1183
- CountryChina
- Language:Chinese
-
Abstract:
Granulocyte is granular leukocytes in blood, which play an important role in anti-infection treatment and cancer-killing activity. In clinical, allogeneic granulocyte transfusion can be applied for anti-infection treatment when the patients are seriously infected but the antibiotic treatment is ineffective, especially the WBC counts are extremely low. Recently, some progress has been made in the researches about treating cancer with granulocyte infusion. It is possible to use allogeneic granulocyte infusion with high killing activity to treat the certain types of cancers.
